Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05441436
Other study ID # 5223
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 26, 2022
Est. completion date May 26, 2025

Study information

Verified date June 2022
Source Hospital Universitario La Paz
Contact Eduardo Fernández-Jiménez, PhD
Phone +34630305521498401
Email eduferjim.psyc@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This pioneering prospective observational study aims to examine biopsychosocial and neuropsychological functioning, care needs and predictors of therapeutic adherence in children/adolescents in pre/post-surgical transplant (solid organ or allogeneic haematopoietic stem cell) phases. Hypothesis: H1. Differences in biopsychosocial and neuropsychological functioning and adherence will be observed between transplant types; H2. Executive functioning will mediate the relationship between anxiety, sleep disturbance and pain intensity/interference and adherence; H3. There will be a significant improvement in different neuropsychological indicators 6 months post-transplantation. Sample: patients (8-18 years) extracted by non-probabilistic sampling, estimating a sample size of 60 patients (30 for each type of transplant, organ and haematopoietic) from Hospital Universitario La Paz (Madrid). Individual pre/post-surgical assessments will be carried out (after 2 and 4 weeks), as well as at 6 months post-transplant, both in person (neurocognitive) and through the secure platform REDCap (completed by patients and their legal guardians). Finally, focus groups will be conducted among patients, their relatives and medical-surgical professionals to identify barriers to therapeutic adherence and unmet care needs during the pre-, peri- and post-surgical process.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date May 26, 2025
Est. primary completion date May 26, 2025
Accepts healthy volunteers No
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria: - Spanish as mother tongue or a very high level of Spanish in order to understand their participation in the study, as well as to be able to complete the measurement instruments. Exclusion Criteria: - Diagnosis of intellectual disability, autism spectrum disorder or acquired brain damage. - Diagnosis of uncontrolled/stabilised comorbid disease, independent of the disease motivating the transplantation process.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic stem cell transplantation
Solid organ transplantation
Solid organ transplantation

Locations

Country Name City State
Spain Hospital Universitario La Paz. Hospital infantil Madrid
Spain University of Málaga Málaga

Sponsors (2)

Lead Sponsor Collaborator
Hospital Universitario La Paz University of Malaga

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Initial survey created ad hoc Both sociodemographic variables (sex, age, patient's level of studies, parents' level of studies) and clinical variables (current pharmacological treatment - active ingredient and dose) will be collected. Baseline
Primary Behavior Rating Inventory of Executive Function - 2 (BRIEF-2) A 63-item questionnaire that assesses patient's executive functions (completed by parents). Higher scores in each domain indicate a worse outcome. Spanish norms in T scores (Mean = 50; standard deviation = 10). Baseline
Primary Behavior Rating Inventory of Executive Function - 2 (BRIEF-2) A 63-item questionnaire that assesses patient's executive functions (completed by parents). Higher scores in each domain indicate a worse outcome. Spanish norms in T scores (Mean = 50; standard deviation = 10). 6 months
Primary Spanish version of the California Verbal Learning Test for children (TAVECI) Assessment of verbal memory in children 3 to 16 years old by the maximum number of remembered elements. Baseline
Primary Spanish version of the California Verbal Learning Test (TAVEC) Assessment of verbal memory for adolescents 16 to 18 years old by the maximum number of remembered elements. Baseline
Primary Spanish version of the California Verbal Learning Test for children (TAVECI) Assessment of verbal memory in children 3 to 16 years old by the maximum number of remembered elements. 6 months
Primary Spanish version of the California Verbal Learning Test (TAVEC) Assessment of verbal memory for adolescents 16 to 18 years old by the maximum number of remembered elements. 6 months
Primary Conners Continuous Auditory Test of Attention (CATA) It measures auditory sustained attention. Omissions and commissions are measured for 5 different dimensions: inattentiveness, impulsivity, sustained attention, auditory laterality and auditory mobility. Baseline
Primary Conners Continuous Auditory Test of Attention (CATA) It measures auditory sustained attention. Omissions and commissions are measured for 5 different dimensions: inattentiveness, impulsivity, sustained attention, auditory laterality and auditory mobility. 4 weeks
Primary Conners Continuous Auditory Test of Attention (CATA) It measures auditory sustained attention. Omissions and commissions are measured for 5 different dimensions: inattentiveness, impulsivity, sustained attention, auditory laterality and auditory mobility. 6 months
Primary Test of Nonverbal Intelligence, Fourth Edition (TONI-4) form A It assesses intellectual functioning free of cultural influences by the total number of items achieved. Baseline
Primary Test of Nonverbal Intelligence, Fourth Edition (TONI-4) form B It assesses intellectual functioning free of cultural influences by the total number of items achieved. 6 months
Primary Digit span subtests from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV): Forward, Backward and Sequencing subtests It evaluates span of immediate recall and verbal working memory by the total number of items achieved and the maximum number of remembered elements. Baseline
Primary Digit span subtests from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV): Forward, Backward and Sequencing subtests It evaluates span of immediate recall and verbal working memory by the total number of items achieved and the maximum number of remembered elements. 4 weeks
Primary Digit span subtests from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV): Forward, Backward and Sequencing subtests It evaluates span of immediate recall and verbal working memory by the total number of items achieved and the maximum number of remembered elements. 6 months
Primary Vocabulary subtest from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) It measures semantic memory by the total number of items achieved. Baseline
Primary Vocabulary subtest from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) It measures semantic memory by the total number of items achieved. 6 months
Primary Symbol Digit Modalities Test (SDMT) It assesses processing speed by the total number of items achieved. Baseline
Primary Symbol Digit Modalities Test (SDMT) It assesses processing speed by the total number of items achieved. 4 weeks
Primary Symbol Digit Modalities Test (SDMT) It assesses processing speed by the total number of items achieved. 6 months
Primary The Rey-Osterrieth Complex Figure (ROCF) test It measures viso-constructive organisational ability and immediate and delayed visual recall. One point is awarded for each component that is properly reproduced. Baseline
Primary The Rey-Osterrieth Complex Figure (ROCF) test It measures viso-constructive organisational ability and immediate and delayed visual recall. One point is awarded for each component that is properly reproduced. 6 months
Primary Fluency Verbal Test (TFV) It assesses linguistic-executive functions such as phonological fluency and semantic fluency. One point is awarded for each word that is correctly produced. Baseline
Primary Fluency Verbal Test (TFV) It assesses linguistic-executive functions such as phonological fluency and semantic fluency. One point is awarded for each word that is correctly produced. 6 months
Primary Behavioral Assessment System for Children - 3 (BASC-3) It measures patients' emotional and behavioural problems, both in its version by the patient's legal guardians and self-reported by the patient. It is an 139-item report, rated on a 4-point frequency Likert scale. High scores indicate problematic levels of functioning. Spanish norms in T scores (Mean = 50; standard deviation = 10). Baseline
Primary Behavioral Assessment System for Children - 3 (BASC-3) It measures patients' emotional and behavioural problems, both in its version by the patient's legal guardians and self-reported by the patient. It is an 139-item report, rated on a 4-point frequency Likert scale. High scores indicate problematic levels of functioning. Spanish norms in T scores (Mean = 50; standard deviation = 10). 6 months
Primary Brief Pain Inventory (BPI) This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life). Higher scores on a Likert scale from 0-10 indicate more pain. Baseline
Primary Brief Pain Inventory (BPI) This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life). Higher scores on a Likert scale from 0-10 indicate more pain. 2 weeks
Primary Brief Pain Inventory (BPI) This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life). Higher scores on a Likert scale from 0-10 indicate more pain. 4 weeks
Primary Brief Pain Inventory (BPI) This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life). Higher scores on a Likert scale from 0-10 indicate more pain. 6 months
Primary Adolescent Insomnia Questionnaire (AIQ) It is a 13-item questionnaire whose original version is in English. In the present study, this questionnaire will be adapted and validated into Spanish. Higher scores on a Likert scale from 0-4 indicate more insomnia. Baseline
Primary Adolescent Insomnia Questionnaire (AIQ) It is a 13-item questionnaire whose original version is in English. In the present study, this questionnaire will be adapted and validated into Spanish. Higher scores on a Likert scale from 0-4 indicate more insomnia. 2 weeks
Primary Adolescent Insomnia Questionnaire (AIQ) It is a 13-item questionnaire whose original version is in English. In the present study, this questionnaire will be adapted and validated into Spanish. Higher scores on a Likert scale from 0-4 indicate more insomnia. 4 weeks
Primary Adolescent Insomnia Questionnaire (AIQ) It is a 13-item questionnaire whose original version is in English. In the present study, this questionnaire will be adapted and validated into Spanish. Higher scores on a Likert scale from 0-4 indicate more insomnia. 6 months
Primary Pediatric Sleep Disturbances Short Form (PROMIS) A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days. Higher scores on a Likert scale from 1-5 indicate worse sleep. Baseline
Primary Pediatric Sleep Disturbances Short Form (PROMIS) A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days. Higher scores on a Likert scale from 1-5 indicate worse sleep. 2 weeks
Primary Pediatric Sleep Disturbances Short Form (PROMIS) A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days. Higher scores on a Likert scale from 1-5 indicate worse sleep. 4 weeks
Primary Pediatric Sleep Disturbances Short Form (PROMIS) A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days. Higher scores on a Likert scale from 1-5 indicate worse sleep. 6 months
Primary Simplified Medication Adherence Questionnaire (SMAQ) A 6-item self-report that measures adherence to medication. For items 1-4 yes or no answers are required. Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided). Item 6 requires a number input. The final score is a dichotomous variable: non-adherent versus adherent patient. Baseline
Primary Simplified Medication Adherence Questionnaire (SMAQ) A 6-item self-report that measures adherence to medication. For items 1-4 yes or no answers are required. Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided). Item 6 requires a number input. The final score is a dichotomous variable: non-adherent versus adherent patient. 2 weeks
Primary Simplified Medication Adherence Questionnaire (SMAQ) A 6-item self-report that measures adherence to medication. For items 1-4 yes or no answers are required. Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided). Item 6 requires a number input. The final score is a dichotomous variable: non-adherent versus adherent patient. 4 weeks
Primary Simplified Medication Adherence Questionnaire (SMAQ) A 6-item self-report that measures adherence to medication. For items 1-4 yes or no answers are required. Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided). Item 6 requires a number input. The final score is a dichotomous variable: non-adherent versus adherent patient. 6 months
See also
  Status Clinical Trial Phase
Completed NCT04985409 - Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant N/A
Recruiting NCT05798286 - Quantra® System With the QPlus® Cartridge in Double-lung Transplantation N/A
Terminated NCT02434146 - Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy Phase 1/Phase 2
Withdrawn NCT03399227 - Liver Transplantation: Skeletal Effects
Recruiting NCT05967130 - Treatment Chronic UTI Post Kidney Transplant Phase 3
Recruiting NCT05600855 - Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model Phase 2
Recruiting NCT05599256 - Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model Phase 2
Completed NCT03811873 - Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates N/A
Completed NCT05629923 - EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTS
Completed NCT03448679 - Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT N/A
Active, not recruiting NCT03769441 - Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation Phase 3
Active, not recruiting NCT03636412 - Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients N/A
Recruiting NCT06066957 - Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients Phase 2
Recruiting NCT03015012 - Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial) N/A
Not yet recruiting NCT06208137 - Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution. N/A
Not yet recruiting NCT04756622 - N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. Phase 3
Available NCT06393660 - Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)